0001209191-23-018505.txt : 20230314 0001209191-23-018505.hdr.sgml : 20230314 20230314164602 ACCESSION NUMBER: 0001209191-23-018505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBIN SHERRINGTON CENTRAL INDEX KEY: 0001619962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 23731681 MAIL ADDRESS: STREET 1: C/O XENON PHARMACEUTICALS INC. STREET 2: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G4W8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-10 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001619962 ROBIN SHERRINGTON 200 - 3650 GILMORE WAY BURNABY A1 V5G 4W8 BRITISH COLUMBIA, CANADA 0 1 0 0 EVP, Strategy & Innovation Stock Option (Right to Buy) 34.18 2023-03-10 4 A 0 75000 0.00 A 2033-03-09 Common Shares 75000 75000 D Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. /s/ Cassandra Robinson, Attorney-in-fact 2023-03-14